Literature DB >> 31168068

Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation.

Tertia D Purves-Tyson1,2, Ulrike Weber-Stadlbauer3, Juliet Richetto3, Debora A Rothmond1, Marie A Labouesse4,5, Marcello Polesel6, Kate Robinson1, Cynthia Shannon Weickert7,8,9, Urs Meyer10,11.   

Abstract

The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02-0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia.

Entities:  

Mesh:

Year:  2019        PMID: 31168068      PMCID: PMC7910216          DOI: 10.1038/s41380-019-0434-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  59 in total

Review 1.  Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems.

Authors:  Urs Meyer
Journal:  Biol Psychiatry       Date:  2013-08-12       Impact factor: 13.382

2.  Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.

Authors:  S G Fillman; N Cloonan; V S Catts; L C Miller; J Wong; T McCrossin; M Cairns; C S Weickert
Journal:  Mol Psychiatry       Date:  2012-08-07       Impact factor: 15.992

3.  Molecular mechanisms and timing of cortical immune activation in schizophrenia.

Authors:  David W Volk; Anjani Chitrapu; Jessica R Edelson; Kaitlyn M Roman; Annie E Moroco; David A Lewis
Journal:  Am J Psychiatry       Date:  2015-07-02       Impact factor: 18.112

Review 4.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.

Authors:  Alan S Brown; Elena J Derkits
Journal:  Am J Psychiatry       Date:  2010-02-01       Impact factor: 18.112

5.  Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation.

Authors:  Vibeke Sørensen Catts; Jenny Wong; Stu Gregory Fillman; Samantha Jane Fung; Cynthia Shannon Weickert
Journal:  Aust N Z J Psychiatry       Date:  2014-04-17       Impact factor: 5.744

Review 6.  Maternal immune activation: Implications for neuropsychiatric disorders.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Science       Date:  2016-08-19       Impact factor: 47.728

Review 7.  Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy.

Authors:  Hans-Gert Bernstein; Johann Steiner; Paul C Guest; Henrik Dobrowolny; Bernhard Bogerts
Journal:  Schizophr Res       Date:  2014-06-16       Impact factor: 4.939

8.  Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.

Authors:  S G Fillman; D Sinclair; S J Fung; M J Webster; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2014-02-25       Impact factor: 6.222

Review 9.  Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.

Authors:  M O Trépanier; K E Hopperton; R Mizrahi; N Mechawar; R P Bazinet
Journal:  Mol Psychiatry       Date:  2016-06-07       Impact factor: 15.992

10.  Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation.

Authors:  Y Zhang; V S Catts; D Sheedy; T McCrossin; J J Kril; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2016-12-13       Impact factor: 6.222

View more
  17 in total

1.  Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes.

Authors:  Sofía Puvogel; Astrid Alsema; Laura Kracht; Cynthia Shannon Weickert; Iris E C Sommer; Bart J L Eggen; Maree J Webster
Journal:  Mol Psychiatry       Date:  2022-10-03       Impact factor: 13.437

2.  What Can We Learn from Animal Models to Study Schizophrenia?

Authors:  Fernanda Crunfli; Caroline Brandão-Teles; Giuliana S Zuccoli; Adriano J M Chaves Filho; Gabriela Maciel Vieira; Danyelle Silva-Amaral; José Alexandre Crippa; João F C Pedrazzi; Danielle S Macêdo; Elaine Del-Bel; Felipe V Gomes
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Distinct Phenotypes of Inflammation Associated Macrophages and Microglia in the Prefrontal Cortex Schizophrenia Compared to Controls.

Authors:  Yunting Zhu; Maree J Webster; Caitlin E Murphy; Frank A Middleton; Paul T Massa; Chunyu Liu; Rujia Dai; Cyndi Shannon Weickert
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

4.  Human umbilical cord-derived mesenchymal stem cells promote repair of neonatal brain injury caused by hypoxia/ischemia in rats.

Authors:  Yang Jiao; Yue-Tong Sun; Nai-Fei Chen; Li-Na Zhou; Xin Guan; Jia-Yi Wang; Wen-Juan Wei; Chao Han; Xiao-Lei Jiang; Ya-Chen Wang; Wei Zou; Jing Liu
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

5.  Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions.

Authors:  Hayley F North; Jason Bruggemann; Vanessa Cropley; Vaidy Swaminathan; Suresh Sundram; Rhoshel Lenroot; Avril M Pereira; Andrew Zalesky; Chad Bousman; Christos Pantelis; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-24       Impact factor: 5.270

6.  Maternal immune activation alters adult behavior, intestinal integrity, gut microbiota and the gut inflammation.

Authors:  Wenqiang Li; Mengxue Chen; Xia Feng; Meng Song; Minglong Shao; Yongfeng Yang; Luwen Zhang; Qing Liu; Luxian Lv; Xi Su
Journal:  Brain Behav       Date:  2021-04-01       Impact factor: 2.708

7.  Alterations in Retrotransposition, Synaptic Connectivity, and Myelination Implicated by Transcriptomic Changes Following Maternal Immune Activation in Nonhuman Primates.

Authors:  Nicholas F Page; Michael J Gandal; Myka L Estes; Scott Cameron; Jessie Buth; Sepideh Parhami; Gokul Ramaswami; Karl Murray; David G Amaral; Judy A Van de Water; Cynthia M Schumann; Cameron S Carter; Melissa D Bauman; A Kimberley McAllister; Daniel H Geschwind
Journal:  Biol Psychiatry       Date:  2020-11-02       Impact factor: 12.810

8.  Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines.

Authors:  Caitlin E Murphy; Adam J Lawther; Maree J Webster; Makoto Asai; Yuji Kondo; Mitsuyuki Matsumoto; Adam K Walker; Cynthia Shannon Weickert
Journal:  J Neuroinflammation       Date:  2020-07-17       Impact factor: 8.322

9.  Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia.

Authors:  Tertia D Purves-Tyson; Kate Robinson; Amelia M Brown; Danny Boerrigter; Helen Q Cai; Christin Weissleder; Samantha J Owens; Debora A Rothmond; Cynthia Shannon Weickert
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

10.  Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia.

Authors:  Tertia D Purves-Tyson; Amelia M Brown; Christin Weissleder; Debora A Rothmond; Cynthia Shannon Weickert
Journal:  Mol Brain       Date:  2021-06-26       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.